ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,504.90
0.52%
S&P 500
5,204.25
0.32%
Dow Jones
39,244.48
0.48%
US Dollar vs Yen
155.501
0.05%
Brent Oil
83.66
0.12%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Proteostasis Therapeutics Inc (PTI)

  7. Proteostasis Therapeutics Inc (PTI) ニュース

PTI

Proteostasis Therapeutics (PTI)

Proteostasis Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PTI
日付受信時刻ニュースソース見出しコード企業名
2023/06/2920 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/2820 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1705 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1323 : 32Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/1306 : 01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/0922 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/06/0205 : 02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/2422 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/2322 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/1206 : 23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/1206 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/05/0305 : 05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906 : 17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906 : 16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2906 : 12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2206 : 14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/2021 : 10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1800 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1506 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1505 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
2023/04/1220 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTI

最近閲覧した銘柄

NYSE
MRK
Merck
NYSE
MCD
McDonalds
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有